I have a background in physics which has evolved into fields of bio-inorganic chemistry and surface science. This has been motivated by applying physical-chemistry concepts and characterization tools to areas of nanotechnology, biotechnology and pharmaceutical sciences.
These interests are being used to develop improvements in understanding disease, therapeutic delivery and pharmaceutical products and novel methodologies for extracting quantitative metrics in determining relevant parameters. This has been a balance between basic and applied research with interest in clinical developments for human health and engaging pharma industries.
My research has been highly multidisciplinary and incorporated strong collaborations world wide for... Read more
About me
I have a background in physics which has evolved into fields of bio-inorganic chemistry and surface science. This has been motivated by applying physical-chemistry concepts and characterization tools to areas of nanotechnology, biotechnology and pharmaceutical sciences.
These interests are being used to develop improvements in understanding disease, therapeutic delivery and pharmaceutical products and novel methodologies for extracting quantitative metrics in determining relevant parameters. This has been a balance between basic and applied research with interest in clinical developments for human health and engaging pharma industries.
My research has been highly multidisciplinary and incorporated strong collaborations world wide for which I have greatly enjoyed the cultural exchange as well as exposure to exceptional research. I have conducted research in the USA, Canada, Japan, England, The Netherlands, Taiwan and China. I have been the recipient of 5 visiting scholar positions in Canada (the Canadian Light Source and Western University), Taiwan (Institute of Physics, Academia Sinica) and China (Institute of Chemistry, Chinese Academy of Sciences).
I enjoy seeing my research published in high impact journals such as Angewandte Chemie, Small, Chemical Society Reviews, Advanced Materials, the Journal of Controlled Release etc. All up I have over 50 publications including 3 invited book chapters. These are giving rise to rapidly growing citations and an h-index of 19 by PubMed.
Exposure of my work has been given by presentation at over 70 international conference presentations. It is especially recognised by delivering 16 international invited and keynote talks in 8 different countries. The general significance is also demonstrated by being invited twice to represent Australia at the International Atomic Energy Agency (IAEA) technical meetings at the UN headquarters in Vienna, Austria.
Other community duties include:
About me
Doctor of Philosophy University of South Australia
Bachelor of Applied Science University of South Australia
Research
Excludes commercial-in-confidence projects.
Nanoparticle regulation of DNA replication and repair pathways, ARC - Discovery Projects, 21/01/2019 - 29/06/2023
Priming cancer for radiotherapy, Tour de Cure Ltd, 01/01/2020 - 30/09/2022
Nanomedicines Immunotargeting: Hitting the Target or Lost In Translation?, NHMRC - Project Grant, 01/01/2013 - 31/12/2016
Research
Research outputs for the last seven years are shown below. Some long-standing staff members may have older outputs included. To see earlier years visit ORCID, ResearcherID or Scopus
Open access indicates that an output is open access.
Year | Output |
---|---|
2020 |
Open access
72
70
1
|
2019 |
Open access
24
21
|
2019 |
Open access
42
43
3
|
2015 |
Open access
97
96
10
|
Year | Output |
---|---|
2024 |
|
2023 |
Open access
21
|
2016 |
|
2012 |
1
1
|
Year | Output |
---|---|
2024 |
Open access
4
|
2024 |
Open access
|
2024 |
Open access
6
1
|
2023 |
Open access
10
8
3
|
2023 |
10
1
|
2023 |
Open access
2
1
|
2022 |
Open access
8
8
8
|
2022 |
10
8
5
|
2022 |
Open access
4
3
|
2022 |
Open access
2
3
|
2022 |
Open access
19
16
4
|
2022 |
Open access
19
17
1
|
2021 |
Open access
417
373
7
|
2021 |
Open access
7
7
|
2021 |
Open access
51
47
|
2021 |
28
27
1
|
2021 |
9
9
|
2020 |
Open access
28
26
2
|
2020 |
Open access
72
70
1
|
2020 |
Open access
1
1
|
2020 |
Open access
6
6
|
2020 |
18
16
3
|
2020 |
Open access
25
23
4
|
2020 |
Open access
6
6
|
2020 |
32
29
|
2019 |
25
24
58
|
2019 |
Open access
51
48
13
|
2019 |
36
35
2
|
2019 |
Open access
23
23
2
|
2019 |
Open access
24
21
|
2019 |
Open access
42
43
3
|
2019 |
14
13
1
|
2018 |
21
18
7
|
2018 |
Open access
10
9
|
2018 |
7
7
11
|
2018 |
Open access
54
47
|
2018 |
67
66
7
|
2017 |
Open access
10
9
1
|
2017 |
Open access
9
9
|
2017 |
Open access
13
13
|
2017 |
Open access
2
2
|
2017 |
Open access
13
12
1
|
2016 |
31
29
|
2015 |
23
23
|
2015 |
Open access
56
55
|
2015 |
Open access
97
96
10
|
2015 |
14
13
|
2014 |
67
134
|
2014 |
4
6
|
2014 |
31
30
|
2014 |
13
25
|
2013 |
9
11
|
2013 |
9
10
|
2013 |
38
35
|
2013 |
Open access
13
12
|
2013 |
24
21
|
2013 |
19
20
|
2013 |
9
9
|
2012 |
25
24
|
2012 |
|
2012 |
19
18
|
2012 |
32
26
|
2012 |
16
14
|
2012 |
42
38
|
2011 |
47
47
|
2011 |
26
23
|
2011 |
Open access
61
56
|
2011 |
Open access
76
70
|
2011 |
Open access
52
51
|
2011 |
151
142
|
2011 |
17
16
|
2011 |
140
128
|
2011 |
107
99
|
2011 |
25
26
|
2011 |
31
27
|
2011 |
28
21
|
2010 |
25
25
|
2010 |
71
64
|
2010 |
25
10
|
2010 |
205
194
|
2010 |
32
32
|
2010 |
20
18
|
2010 |
70
66
|
2010 |
Open access
26
21
|
2009 |
31
29
|
2009 |
19
19
|
2009 |
62
56
|
2008 |
40
35
|
2008 |
42
39
|
Research
Research
Details | Registry | Status |
---|---|---|
Nanoparticle cancer therapy Kempson, Ivan; Turnbull, Tyron |
US | Filed |
External engagement & recognition
Organisation | Country |
---|---|
Academia Sinica | TAIWAN |
Argonne National Laboratory | UNITED STATES |
Australian Nuclear Science and Technology Organisation | AUSTRALIA |
Australian Synchrotron | AUSTRALIA |
Brookhaven National Laboratory | UNITED STATES |
Chang Gung University of Science and Technology | TAIWAN |
China Medical University, Taiwan | TAIWAN |
Chinese Academy of Sciences | CHINA |
Chung Yuan Christian University | TAIWAN |
City University of Hong Kong (CityU) | HONG KONG |
Commonwealth Department of the Environment and Water Resources | AUSTRALIA |
CSIRO Australia (Commonwealth Scientific Industrial Research organisation) | AUSTRALIA |
Dana-Farber Cancer Institute | UNITED STATES |
Ecole Polytechnique | FRANCE |
Fermiscan Holdings Ltd. | AUSTRALIA |
Flinders University | AUSTRALIA |
Harvard University | UNITED STATES |
Heifei University of Technology | CHINA |
Institute of Medical and Veterinary Science | AUSTRALIA |
Kaohsiung Medical University | TAIWAN |
Lincoln University | NEW ZEALAND |
Mackay Memorial Hospital | TAIWAN |
Museum of Victoria | AUSTRALIA |
National Center for High-Performance Computing | TAIWAN |
National Cheng Kung University | TAIWAN |
National Chiayi University | TAIWAN |
National Chung Hsing University | TAIWAN |
National Defense Medical Center | TAIWAN |
National Health Research Institute | CHINA |
National Health Research Institutes | TAIWAN |
National Sun Yat-Sen University | TAIWAN |
National Synchrotron Radiation Research Centre | TAIWAN |
National Synchrotron Radiation Research Centre (NSSRC) | TAIWAN |
National Taiwan Ocean University | TAIWAN |
National Taiwan University | TAIWAN |
National Taiwan University College of Medicine | TAIWAN |
National Taiwan University Hospital | TAIWAN |
National Tsing Hua University | TAIWAN |
National University of Singapore | SINGAPORE |
National Yunlin University of Science and Technology | TAIWAN |
niversity of Notre Dame | UNITED STATES |
Paris-Saclay University | FRANCE |
pSiMedica Ltd | UNITED KINGDOM |
Queensland University of Technology | AUSTRALIA |
Royal Adelaide Hospital | AUSTRALIA |
Southeast University | CHINA |
Sun Yat-Sen University | CHINA |
Swiss Federal Institute of Technology Lausanne | SWITZERLAND |
Tatung University | TAIWAN |
Tehran University of Medical Sciences | IRAN |
Tunghai University | TAIWAN |
University College London | UNITED KINGDOM |
University of Adelaide | AUSTRALIA |
University of Bordeaux | FRANCE |
University of Erlangen-Nuremberg | GERMANY |
University of Queensland | AUSTRALIA |
University of Siegen | GERMANY |
University of South Australia | AUSTRALIA |
University of Sydney | AUSTRALIA |
University of Tasmania | AUSTRALIA |
University of Technology Sydney | AUSTRALIA |
US Environmental Protection Agency | UNITED STATES |
Western University | CANADA |
External engagement & recognition
Engagement/recognition | Year |
---|---|
College of ExpertsAustralian Research Council |
2024 |
College of ExpertsAustralian Research Council |
2023 |
Committee MemberRomania's National Recovery and Resilience Plan - The Executive Agency for Higher Education, Research, Development and Innovation Funding |
2023 |
Editorial Board MemberRadiation |
2023 |
Editorial Board MemberInternational Journal of Molecular Sciences |
2023 |
International ExpertKazakhstan National Centre of Science and Technology Evaluation |
2023 |
Invited membershipSigma Xi, The Scientific Research Honour Society |
2023 |
MemberAustralian Radiation Protection Society |
2023 |
MemberAustralian and New Zealand Society of Nuclear Medicine |
2023 |
MRFF Grant Assessment Committee, Panel MemberMedical Research Future Fund |
2023 |
NHMRC Development Grant Panel MemberNational Health and Medical Research Council |
2023 |
$4000000 grantAustralian Cancer Research Foundation |
2022 |
College of ExpertsAustralian Research Council |
2022 |
Committee MemberRomania's National Recovery and Resilience Plan - The Executive Agency for Higher Education, Research, Development and Innovation Funding |
2022 |
Editorial Board MemberInternational Journal of Molecular Sciences |
2022 |
Editorial Board MemberRadiation |
2022 |
International ExpertKazakhstan National Centre of Science and Technology Evaluation |
2022 |
International Journal of Molecular Sciences Best PaperMDPI |
2022 |
Invited membershipMark Hughes Foundation for Brain Cancer Research |
2022 |
Invited membershipSigma Xi, The Scientific Research Honour Society |
2022 |
Invited speakerInternational Conference on Nanomedicine |
2022 |
Invited speakerIUPESM World Congress, June, 2022, Singapore |
2022 |
Invited speaker12th International Nanomedicine Conference, 27-29 June 2022, Sydney |
2022 |
Invited speaker8th International Symposium on Metallomics, Kanazawa, 11-14 July 2022, Japan |
2022 |
Invited speakerMark Hughes Foundation for Brain Cancer Research Symposium |
2022 |
MemberAustralian Radiation Protection Society |
2022 |
MemberAustralian and New Zealand Society of Nuclear Medicine |
2022 |
MRFF Grant Assessment Committee, Panel MemberMedical Research Future Fund |
2022 |
NHMRC Development Grant Panel MemberNational Health and Medical Research Council |
2022 |
Visiting ProfessorFAU Erlangen-Nürnberg |
2022 |
Editorial Board MemberInternational Journal of Molecular Sciences |
2021 |
Editorial Board MemberInternational Journal of Molecular Sciences |
2020 |
Invited speakerANSTO User Meeting, 19-20 Nov, 2020 |
2020 |
Editorial Board MemberInternational Journal of Molecular Sciences |
2019 |
Invited speaker17th International Conference on Biomedical Engineering (ICBME) 2019, 9 – 12 December, Singapore |
2019 |
Invited speakerNanomedicine, 24-26 June, 2019, Sydney |
2019 |
Invited speakerEngineering and Physical Sciences in Medicine, November 2018, Adelaide |
2018 |
MemberAmerican Chemical Society (ACS) |
2018 |
Certificate in Recognition of Work (First ever foreign recipient)Supreme Public Prosecutors Office, Taiwan |
2017 |
MemberAmerican Chemical Society (ACS) |
2017 |
National Representation at the International Atomic Energy AgencyTrends in Analytical Applications and Instrumental Developments of Synchrotron Based X-Ray Spectrometry Techniques, Vienna, Austria, 2-6 October |
2017 |
Keynote SpeakerWorld Congress on Medical Physics and Biomedical Engineering |
2015 |
Keynote Speaker16th International Workshop on Radiation Imaging Detectors, Italy |
2014 |
Teaching & student supervision
Teaching & student supervision
Supervisions from 2010 shown
Thesis title | Student status |
---|---|
110450 - Development of a theranostic agent for image-guided and radiosensitisation of pancreatic cancer | Current |
Flash-proton therapy: synergistic normal tissue sparing with heavy ions at ultra-high dose rates | Current |
Investigation of radiosensitization mechanisms using gold and aluminium nanoparticles under clinical beam radiation in the 4T1 mouse model of breast cancer | Current |
Percutaneous absorption: insights towards a mechanistic understanding of skin disease, topical product and end-user effects | Current |
Single cell analysis of nanoparticle uptake: Impact of environmental plastic pollutants | Current |
Tumour cell population heterogeneity: Therapeutic challenges and opportunities | Current |
Development of a tumour microenvironment sensitive polymeric nanoparticle to formulate multiple chemotherapy agents for cancer treatment | Completed |
Fundamental understanding, development and industrial applications of copper binding glutaraldehyde-polyethyleneimine coatings: antifouling, remediation, and sensing | Completed |
High density lipoprotein: a natural multi-functional nanomedicine for targeted delivery of radiosensitisers to the tumour microenvironment | Completed |
Linking the intracellular journey of gold nanoparticles to protein expression changes in prostate cancer cells | Completed |
Radiosensitization of cell sub-populations by gold nanoparticles: cross-correlative microscopy for elucidating fundamental mechanisms | Completed |
Single cell analysis of gold and gold-core/silica-shell nanoparticles for radiosensitisation | Completed |
Stochastic modelling of gold nanoparticle enhancement of dose and reactive species yield for proton therapy | Completed |
Unravelling biochemical effects of radiosensitizing gold nanoparticles on cancer cells at the cell population, single-cell, and molecular levels | Completed |